Literature DB >> 22284378

Central nervous system device infections.

Edward Stenehjem1, Wendy S Armstrong.   

Abstract

Infections of central nervous system (CNS) devices are relatively common and potentially severe. The most common devices associated with infection are ventriculostomy catheters, shunts, and deep brain stimulators. The prevention, diagnosis, and management of these infections require a collaborative approach because of the complexity of surgery, the nuances of antimicrobial delivery in the CNS, and the potential for severe morbidity and mortality. This article focuses on new developments in the management and prevention of intracranial device infections, in particular ventriculostomy-related infections and infections of deep brain stimulators.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22284378     DOI: 10.1016/j.idc.2011.09.006

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  13 in total

1.  Risk of Resistant Organisms and Clostridium difficile with Prolonged Systemic Antibiotic Prophylaxis for Central Nervous System Devices.

Authors:  Stephanie Chauv; Gabriel V Fontaine; Quang P Hoang; Courtney B McKinney; Margaret Baldwin; Whitney R Buckel; Dave S Collingridge; Sarah Majercik; Paul D Wohlt
Journal:  Neurocrit Care       Date:  2016-08       Impact factor: 3.210

Review 2.  Intrathecal/intraventricular colistin in external ventricular device-related infections by multi-drug resistant Gram negative bacteria: case reports and review.

Authors:  O Bargiacchi; A Rossati; P Car; D Brustia; R Brondolo; F Rosa; P L Garavelli; F G De Rosa
Journal:  Infection       Date:  2014-04-12       Impact factor: 3.553

Review 3.  Healthcare-Associated Infections in the Neurocritical Care Unit.

Authors:  Katharina M Busl
Journal:  Curr Neurol Neurosci Rep       Date:  2019-08-27       Impact factor: 5.081

4.  Cerebrospinal Fluid Shunt Infection: Emerging Paradigms in Pathogenesis that Affect Prevention and Treatment.

Authors:  Tamara D Simon; Joshua K Schaffzin; Charles B Stevenson; Kathryn Willebrand; Matthew Parsek; Lucas R Hoffman
Journal:  J Pediatr       Date:  2018-12-06       Impact factor: 4.406

5.  2017 Infectious Diseases Society of America's Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis.

Authors:  Allan R Tunkel; Rodrigo Hasbun; Adarsh Bhimraj; Karin Byers; Sheldon L Kaplan; W Michael Scheld; Diederik van de Beek; Thomas P Bleck; Hugh J L Garton; Joseph R Zunt
Journal:  Clin Infect Dis       Date:  2017-03-15       Impact factor: 9.079

6.  Central nervous system infection after Onyx embolisation of arterio-venous malformations in two paediatric patients.

Authors:  H Pulhorn; J C Hartley; M Shanmuganathan; C H Lee; W Harkness; D N P Thompson
Journal:  Childs Nerv Syst       Date:  2014-06-04       Impact factor: 1.475

7.  Intraventricular tissue plasminogen activator in subarachnoid hemorrhage patients: a prospective, randomized, placebo-controlled pilot trial.

Authors:  Andreas H Kramer; Derek J Roberts; Jessalyn Holodinsky; Stephanie Todd; Michael D Hill; David A Zygun; Peter Faris; John H Wong
Journal:  Neurocrit Care       Date:  2014-10       Impact factor: 3.210

Review 8.  Systematic Review of Efficacy, Pharmacokinetics, and Administration of Intraventricular Aminoglycosides in Adults.

Authors:  Marlys LeBras; Ivy Chow; Vincent H Mabasa; Mary H H Ensom
Journal:  Neurocrit Care       Date:  2016-12       Impact factor: 3.210

9.  Bacterial infections of the central nervous system.

Authors:  Katharina M Busl; Thomas P Bleck
Journal:  Curr Infect Dis Rep       Date:  2013-12       Impact factor: 3.663

10.  Update on deep brain stimulation in Parkinson's disease.

Authors:  Daniel Martinez-Ramirez; Wei Hu; Alberto R Bona; Michael S Okun; Aparna Wagle Shukla
Journal:  Transl Neurodegener       Date:  2015-06-27       Impact factor: 8.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.